Department of Clinical Analysis, São Paulo State University, UNESP, Araraquara, SP 14801-903, Brazil.
Behav Brain Res. 2010 Dec 20;215(1):122-8. doi: 10.1016/j.bbr.2010.07.010. Epub 2010 Jul 16.
The 5-hydroxytryptamine (5-HT)(1A) receptor system plays a prominent role in a variety of physiological functions and behavior and regulation of this responsiveness of the receptor system has been implicated in the central regulation of water intake and urinary excretion. The lateral septal area (LSA) exhibits a high density of 5-HT(1A) receptors, as well as a subpopulation of oxytocin (OT) receptors. Here we report the effects of pMPPF (a selective 5-HT(1A) antagonist), d(CH(2))(5)[Tyr(Me)(2)Thr(4), Orn(5), Tyr(NH(2))(9)]-vasotocin (an OT antagonist), and that 5-HT(1A) receptor system is regulated as a consequence of activation of the Na(+) channel by veratridine. Cannulae were implanted into the LSA of rats to enable the introduction of the drugs. Injections of 8-OH-DPAT (a 5-HT(1A) agonist) blocked water intake and increased urinary excretion, while pMPPF or the OT antagonist injected bilaterally before 8-OH-DPAT blocked its inhibitory effect on water intake and its diuretic effect. In contrast, increases in extracellular sodium levels induced by the sodium channel modulator, veratridine, enhanced 5-HT(1A) responsiveness for water intake and reduced the diuretic effects induced by 8-OH-DPAT. These trials demonstrated that the responsiveness of the 5-HT(1A) receptor system in the LSA can be enhanced or depressed as a consequence of an induced rise in extracellular sodium.
5-羟色胺(5-HT)(1A)受体系统在各种生理功能和行为中起着重要作用,调节该受体系统的反应性与中枢调节水摄入和尿排泄有关。侧隔区(LSA)表现出高密度的 5-HT(1A)受体,以及催产素(OT)受体的亚群。在这里,我们报告了 pMPPF(一种选择性 5-HT(1A)拮抗剂)、d(CH(2))(5)[Tyr(Me)(2)Thr(4),Orn(5),Tyr(NH(2))(9)]-血管加压素(OT 拮抗剂)的作用,以及 5-HT(1A)受体系统作为钠离子通道激活的结果而受到调节。在大鼠的 LSA 中植入了套管,以便能够引入药物。8-OH-DPAT(5-HT(1A)激动剂)的注射阻断了水的摄入并增加了尿的排泄,而 pMPPF 或 OT 拮抗剂在 8-OH-DPAT 之前双侧注射阻断了其对水摄入的抑制作用及其利尿作用。相比之下,钠离子通道调节剂藜芦碱引起的细胞外钠离子水平升高增强了 LSA 中 5-HT(1A)对水摄入的反应性,并降低了 8-OH-DPAT 引起的利尿作用。这些试验表明,LSA 中 5-HT(1A)受体系统的反应性可以作为细胞外钠离子升高的结果而增强或减弱。